Artigos Científicos

dr. edgard reis

Dr. Edgard Reis está sempre colaborando com a comunidade médica e publica constantemente os resultados dos seus mais de 15 anos de experiência médica, através de artigos científicos e capítulos de livros.

Veja abaixo alguns dos artigos científicos publicados:

II Brazilian Society of Rheumatology consensus for lupus nephritis diagnosis and treatment

Position statement of the Brazilian society of Rheumatology on mesna use as a preventive therapy for bladder disease in patients with systemic autoimmune diseases and systemic vasculitis under cyclophosphamide treatment

Life expectancy and death pattern associated with systemic lupus erythematosus diagnosis in Brazil between 2000 and 2019

Socioeconomic factors and COVID-19 mortality in immune-mediated rheumatic diseases patients: regional analysis from Argentina, Mexico and Brazil

Factors Associated With Mortality in Patients With Immune-Mediated Rheumatic Diseases and COVID-19 From Latin America: Data From Argentina, Mexico, and Brazil

Development of an instrument to predict proliferative histological class in lupus nephritis based on clinical and laboratory data.

Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer

Factors associated with poor outcomes in SLE patients with COVID-19: Data from ReumaCoV-Brazil register.

COVID-19 was not associated or trigger disease activity in spondylarthritis patients

Participating as a research team during the COVID-19 pandemic benefits mental health of undergraduate medical students in Brazil.

Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.

Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registry.

The Role of Autoantibody Testing in Modern Personalized Medicine.

Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance.

Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force.

A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group.

Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.

Effects of Participating in a Research Project During the COVID-19 Pandemic on Medical Students’ Educational Routines and Mental Health: Protocol for a Web-Based Survey Study.

Serum Myostatin and Follistatin Levels in Patients With Dermatomyositis and Polymyositis.

Let’s Talk About Lupus. Overview of an Innovative, High-Reach, Online Program to Fill the Education Gaps of Latin Americans Living With Lupus.

Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil.

A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group.

Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.

Effects of Participating in a Research Project During the COVID-19 Pandemic on Medical Students’ Educational Routines and Mental Health: Protocol for a Web-Based Survey Study.

High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry.

A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study.

Characteristics associated with COVID-19 vaccine hesitancy: A nationwide survey of 1000 patients with immune-mediated inflammatory diseases.

COVID-19 in patients with rheumatic diseases: what is the real mortality risk?

Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases.

Doenças Reumáticas imunomediadas e aterosclerose.

Transverse Myelitis in Systemic Lupus Erythematosus: Clinical Features and Prognostic Factors in a Large Cohort of Latin American Patients.

Incidence of Cytomegalovirus Antigenemia in patients with autoimmune rheumatic diseases: a 3-year retrospective study.

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR).

Transverse Myelitis in Systemic Lupus Erythematosus: Clinical Features and Prognostic Factors in a Large Cohort of Latin American Patients.

Incidence of Cytomegalovirus Antigenemia in patients with autoimmune rheumatic diseases: a 3-year retrospective study.

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR).

Could obesity be considered as risk factor for non-vertebral low-impact fractures?

The relevance of performing exercise test before starting supervised physical exercise in asymptomatic cardiovascular patients with rheumatic diseases.

Prevalence of musculoskeletal symptoms in the five urban regions of Brazil – the Brazilian COPCORD study (BRAZCO).

Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus.

The effect of acute physical exercise on cytokine levels in patients with systemic lupus erythematosus.

The skin tissue is adversely affected by TNF-alpha blockers in patients with chronic inflammatory arthritis: a 5-year prospective analysis.

Development and validation of a tool for identifying women with low bone mineral density and low-impact fractures: the São Paulo Osteoporosis Risk Index (SAPORI).

Switching Between Anti-Tnf-Alpha Agents Does Not Improve Functional Capacity In Patients With Long-Standing And Active Rheumatoid Arthritis.

Antiplatelet Therapy for the Prevention of Arterial Ischemic Events in Takayasu Arteritis.

Lepromatous leprosy associated with the use of anti-TNF alpha therapy: case report.

Risk factors for osteoporotic fractures and low bone density in pre and postmenopausal women.

Risk factors for cardiovascular disease and endothelin-1 levels in Takayasu arteritis patients.

Miopatias inflamatórias no idoso

Thoracic outlet syndrome (TOS) mimicking Takayasu’s arteritis – Case report.

Turbeculose cutânea disseminada com escrofuloderma associado à tuberculose de arco costal.